ANN ARBOR, Mich. — September 25, 2019 — Kraig Biocraft Laboratories Inc., a developer of spider silk based fibers, announces today that, with the appointment of Greg Scheessele, as the third and final independent board member, it has completed the selection of independent members for its board of directors.
Scheessele currently serves as the CEO of Gerette LLC and has held several top executive roles in global manufacturing firms including: executive vice president, TMD Americas at TMD Friction Holdings GmbH; group vice president, Global Operations at Pall Corp. and Gelman Sciences; and manufacturing manager at General Motors Powertrain Division. Scheessele has served on various corporate and non-profit boards over the past 12 years.
Over the last two weeks the company announced the selections of three new independent directors scheduled to join the company’s board during the fourth quarter, including Anurag Gupta, Julie Bishop, and Greg Scheessele. The company anticipates selecting one additional inside director to round out its board.
“We are pleased to welcome Greg to the Kraig Lab’s board in the role of an independent director,” said chairman and CEO, Kim Thompson. “Greg’s background, experience, and leadership focused in businesses with global operations in manufacturing, industrial and life sciences sectors will be a tremendous asset to our corporate strategy as we continue on our growth trajectory. With this announcement, the company has reached a new and important milestone in its corporate governance, advancing our business model.”
The addition of Scheessele to the board will expand the overall skillset, perspective and experience necessary to support and drive growth for all of the Company’s stakeholders. Scheessele has a strong history of leading successful business operations on a global scale.
Scheessele’s term will begin during the fourth quarter and he will serve on the audit and compensation committees for the duration of his time as a director.
Once these three new independent directors are formally seated, during the fourth quarter, the company will be governed by a majority of independent directors, which is a key requirement for listing on a national exchange.
“I am very excited to join the Kraig Biocraft Laboratories board,” said Scheessele. “I look forward to supporting Kim Thompson and his team with their exciting work focusing on the development and commercialization of spider silk.”
Posted September 26, 2019
Source: Kraig Biocraft Laboratories Inc.
